GlassScriptPhysician profile
Myriam Langer
NPI 1255584306
$473.10
in general payments reported to CMS, 2019-2025
12 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.04 · 2020: $30.44 · 2021: $42.81 · 2024: $110 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $231.32 | 2024-2025 | |
| Astellas Pharma US INC | $42.19 | 2025 | Veozah |
| Coopersurgical, INC. | $31.54 | 2025 | Ally II Ups |
| Smith+Nephew, INC. | $30.44 | 2020 | |
| Janssen Biotech, INC. | $29.20 | 2019 | |
| Exeltis, USA INC. | $21.35 | 2025 | Slynd |
| Organon LLC | $17.41 | 2024 | |
| Hologic Sales and Service, LLC | $16.51 | 2021 | |
| Amarin Pharma, INC. | $14.59 | 2021 | |
| Merck Sharp & Dohme LLC | $13.99 | 2019 | |
| Avion Pharmaceuticals | $12.85 | 2019 | |
| Evofem Biosciences, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myriam Langer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.